Empagliflozin in Patients with Chronic Kidney Disease,The New England Journal of Medicine

当前位置： X-MOL 学术 › N. Engl. J. Med. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Empagliflozin in Patients with Chronic Kidney Disease
The New England Journal of Medicine ( IF 96.2 ) Pub Date : 2022-11-04 , DOI: 10.1056/nejmoa2204233
, William G Herrington ₁ , Natalie Staplin ₁ , Christoph Wanner ₁ , Jennifer B Green ₁ , Sibylle J Hauske ₁ , Jonathan R Emberson ₁ , David Preiss ₁ , Parminder Judge ₁ , Kaitlin J Mayne ₁ , Sarah Y A Ng ₁ , Emily Sammons ₁ , Doreen Zhu ₁ , Michael Hill ₁ , Will Stevens ₁ , Karl Wallendszus ₁ , Susanne Brenner ₁ , Alfred K Cheung ₁ , Zhi-Hong Liu ₁ , Jing Li ₁ , Lai Seong Hooi ₁ , Wen Liu ₁ , Takashi Kadowaki ₁ , Masaomi Nangaku ₁ , Adeera Levin ₁ , David Cherney ₁ , Aldo P Maggioni ₁ , Roberto Pontremoli ₁ , Rajat Deo ₁ , Shinya Goto ₁ , Xavier Rossello ₁ , Katherine R Tuttle ₁ , Dominik Steubl ₁ , Michaela Petrini ₁ , Dan Massey ₁ , Jens Eilbracht ₁ , Martina Brueckmann ₁ , Martin J Landray ₁ , Colin Baigent ₁ , Richard Haynes ₁

Affiliation

The affiliations of the members of the writing committee are as follows: the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (W.G.H., N.S., J.R.E., D.P., P.J., K.J.M., S.Y.A.N., E.S., D.Z., M.H., W.S., K.W., M.J.L., C.B., R.H.), and the Medical Research Council Population Health Research Unit (W.G.H., N.S., J.R.E., D.P., M.H., M.J.L., C.B., R.H.), University of Oxford, Oxford; University Clinic Würzburg, Würzburg (C.W., S.B.), Boehringer Ingelheim International (S.J.H., D.S., J.E., M.B.) and Boehringer Ingelheim Pharmaceuticals (M.P.), Ingelheim am Rhein, Elderbrook Solutions, Bietigheim-Bissingen (D.M.), the Fifth Department of Medicine, University Medical Center Mannheim (S.J.H.) and the First Department of Medicine, Faculty of Medicine Mannheim (M.B.), University of Heidelberg, Mannheim, and the Department of Nephrology, Hospital Rechts der Isar, Technical University of Munich, Munich (D.S.) - all in Germany; Duke Clinical Research Institute, Durham, NC (J.B.G.); University of Utah, Salt Lake City (A.K.C.); National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing (Z.-H.L.), and Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases, Beijing (J.L.) - both in China; Hospital Sultanah Aminah, Johor Bahru, Malaysia (L.S.H., W.L.); the University of Tokyo School of Medicine, Toranomon Hospital (T.K.), and the University of Tokyo School of Medicine (M.N.), Tokyo, Tokai University School of Medicine, Isehara (S.G.) - both in Japan; University of British Columbia, Vancouver (A.L.), and University of Toronto, Toronto (D.C.) - both in Canada; Università degli Studi and IRCCS Ospedale Policlinico San Martino di Genova, Genoa (R.P.), and Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence (A.P.M.) - both in Italy; University of Pennsylvania Perelman School of Medicine, Philadelphia (R.D.); Providence Health, Renton, and University of Washington, Seattle (K.R.T.) - both in Washington; and Hospital Universitari Son Espases, Health Research Institute of the Balearic Islands, University of the Balearic Islands, Palma de Mallorca, Spain (X.R.).

New England Journal of Medicine, Ahead of Print.

中文翻译：